LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

21.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-7.7M -26M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.45
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

161 / 344 Ranking in Healthcare

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Mai 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Family Offices Bypass Private Equity and Go Direct -- Barrons.com

29. Mai 2026, 23:06 UTC

Akquisitionen, Fusionen, Übernahmen

After a Series of Sales, Hims Director Buys Company Shares -- Barrons.com

29. Mai 2026, 20:53 UTC

Ergebnisse

Oil Declines Lift Stocks to Fresh Records -- WSJ

29. Mai 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 20:33 UTC

Market Talk

Canada Meets Only One of Three Criteria To Declare Recession -- Market Talk

29. Mai 2026, 20:11 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 19:47 UTC

Ergebnisse

These Were the Best and Worst S&P 500 Stocks in May -- Barrons.com

29. Mai 2026, 19:36 UTC

Market Talk

U.S. Natural Gas Futures End Month With Gains -- Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

29. Mai 2026, 19:34 UTC

Market Talk

Over Half of Canadian Industries Growing, Undermining Recession Talk -- Market Talk

29. Mai 2026, 19:22 UTC

Market Talk

Oil Falls as U.S., Iran Expected to Reach Agreement -- Market Talk

29. Mai 2026, 19:05 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Takeover Bid From Bill Ackman's Pershing Square -- Barrons.com

29. Mai 2026, 18:19 UTC

Market Talk

Canada Technical Recession Chatter Rife But Per-Capita GDP Was Up -- Market Talk

29. Mai 2026, 18:12 UTC

Akquisitionen, Fusionen, Übernahmen

Universal Music Group Rejects $65 Billion Buyout Offer From Bill Ackman -- WSJ

29. Mai 2026, 18:11 UTC

Market Talk

Canada Households Reaching Limit at Keeping Spending in Positive Territory -- Market Talk

29. Mai 2026, 18:10 UTC

Market Talk

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29. Mai 2026, 17:55 UTC

Ergebnisse

Okta Stock Soars. What's Stealing the Show From Earnings. -- Barrons.com

29. Mai 2026, 17:55 UTC

Market Talk

NEAR Protocol Nearly Doubles in May -- Market Talk

29. Mai 2026, 17:38 UTC

Market Talk

U.S. Oil Rig Count Rises for Fifth Straight Week -- Market Talk

29. Mai 2026, 17:00 UTC

Ergebnisse

Okta Stock Soars After Earnings. Results Aren't the Real Catalyst. -- Barrons.com

29. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

29. Mai 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

29. Mai 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

29. Mai 2026, 16:02 UTC

Market Talk

Gold Extend Gains as Investors Await U.S.-Iran Deal News -- Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Global Equities Roundup: Market Talk

29. Mai 2026, 15:55 UTC

Market Talk

Cryptocurrencies Appear Detached From Stocks -- Market Talk

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Cormetech Acquisition to Drive Growth

29. Mai 2026, 15:50 UTC

Akquisitionen, Fusionen, Übernahmen

Johnson Matthey CEO: Demand for AI Data Centers Insatiable

29. Mai 2026, 15:40 UTC

Market Talk

Kalshi To Launch Crypto Perpetual Futures -- Market Talk

29. Mai 2026, 15:20 UTC

Market Talk

Canada's Economy Not Looking All That Bright -- Market Talk

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Stimmung

By Acuity

161 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.